Dr. Shokunbi's F-202 S.D. Sugar Diabetes Compound
Dr. Shokunbi's F-202 S.D. Sugar Diabetes Compound
- Description
- The indications or uses for this product as provided by the manufacturer are:
- Tonic useful for those who suffer with sugar diabetes, and as an aid in the elimination of sugar in the urine. F-218: general tonic indicated for relief of high or low blood pressure, kidney and bladder, rheumatic pain, gas on stomach, nervousness, cough due to cold, chronic bronchitis, asthma, arthritis, backache.
- Location
- Currently not on view
- Object Name
- otc preparation
- Other Terms
- Patent Medicines; Drugs; Liquid
- maker
- African Herb and Chemical Company
- place made
- United States: Illinois, Chicago
- Physical Description
- raspberry leaves (drug active ingredients)
- red clover tops (drug active ingredients)
- cinchona bark (drug active ingredients)
- yarrow herb (drug active ingredients)
- horsetail grass (drug active ingredients)
- peppermint leaves (drug active ingredients)
- rosemary seed (drug active ingredients)
- Measurements
- overall: 7 3/4 in x 2 3/4 in x 1 7/8 in; 19.685 cm x 6.985 cm x 4.7625 cm
- ID Number
- MG.274347.217
- catalog number
- 274347.217
- accession number
- 274347
- subject
- Tonics, Minerals & Vitamins
- Catarrh, Cough & Cold Drugs
- Respiratory & Asthma Drugs
- See more items in
- Medicine and Science: Medicine
- Balm of America
- Data Source
- National Museum of American History
Our collection database is a work in progress. We may update this record based on further research and review. Learn more about our approach to sharing our collection online.
If you would like to know how you can use content on this page, see the Smithsonian's Terms of Use. If you need to request an image for publication or other use, please visit Rights and Reproductions.
Note: Comment submission is temporarily unavailable while we make improvements to the site. We apologize for the interruption. If you have a question relating to the museum's collections, please first check our Collections FAQ. If you require a personal response, please use our Contact page.